Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Dec;160(6):e639-e643.
doi: 10.1016/j.chest.2021.07.051.

A 31-Year-Old Man With Seizures, Brain Lesion, and Lung Nodules

Affiliations
Case Reports

A 31-Year-Old Man With Seizures, Brain Lesion, and Lung Nodules

Luis Patricio Maskin et al. Chest. 2021 Dec.

Abstract

A 31-year-old man was admitted to our hospital with a recent history of generalized seizures. Three months earlier, he started with intermittent hemoptysis. CT scan showed a cavitary lung lesion in the upper segment of the right inferior lobe (RIL). Because of his job as a social worker in a high-risk population, he started treatment for Mycobacterium TB; however, the BAL culture result was negative. At the time of his current admission, he has continued taking rifampicin, isoniazid, pyrazinamide, and levofloxacin. He denied the use of any illicit drugs or alcohol. He had no history of smoking. One year earlier, he visited Southeast Asia, Oceania, and South Africa for several months. He reported a weight loss of 7 kg since then. Except for a recurrent oral candidiasis, he did not have a relevant medical history. His family history was notable for mother with lupus, and brother with sarcoidosis.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chest CT scan shows a nodular lung lesion in the upper segment of the right inferior lobe.
Figure 2
Figure 2
Brain MRI showing a right temporal-occipital nodule, which enhances with contrast.
Figure 3
Figure 3
Lung biopsy demonstrated noncaseating granulomas with giant cells (A, hematoxylin-eosin strain, 100×), and giant cell (B, hematoxylin-eosin strain, 200×).

Comment in

  • Response.
    Maskin LP, Garcia Hernandez MH, Stryjewski ME, Rodriguez PO. Maskin LP, et al. Chest. 2022 May;161(5):e327-e328. doi: 10.1016/j.chest.2022.01.028. Chest. 2022. PMID: 35526908 No abstract available.
  • Dihydrorhodamine Test From a Clinical Point of View.
    Mahendran AJ, Gupta N. Mahendran AJ, et al. Chest. 2022 May;161(5):e327. doi: 10.1016/j.chest.2022.01.027. Chest. 2022. PMID: 35526909 No abstract available.

References

    1. Bassiri-Jahromi S., Doostkam A. Fungal infection and increased mortality in patients with chronic granulomatous disease. J Mycol Med. 2012;22:52–57. - PubMed
    1. Dotis J., Pana Z.D., Roilides E. Non-Aspergillus fungal infections in chronic granulomatous disease. Mycoses. 2013;56:449–462. - PubMed
    1. Marciano B.E., Spalding C., Fitzgerald A., et al. Common severe infections in chronic granulomatous disease. Clin Infect Dis. 2015;60:1176–1183. - PMC - PubMed
    1. Rawat A., Bhattad S., Singh S. Chronic granulomatous disease. Indian J Pediatr. 2016;83:345–353. - PubMed
    1. Thomsen I.P., Smith M.A., Holland S.M., Creech C.B. A comprehensive approach to the management of children and adults with chronic granulomatous disease. J Allergy Clin Immunol Pract. 2016;4:1082–1088. - PubMed

Publication types

Substances

Supplementary concepts